tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AnaptysBio Files Legal Complaint Against GSK and Tesaro
PremiumCompany AnnouncementsAnaptysBio Files Legal Complaint Against GSK and Tesaro
2M ago
Buy Rating for AnaptysBio Amid Legal Dispute with Tesaro Over Jemperli Rights
Premium
Ratings
Buy Rating for AnaptysBio Amid Legal Dispute with Tesaro Over Jemperli Rights
2M ago
AnaptysBio Sues TESARO Over License Agreement Breach
Premium
Company Announcements
AnaptysBio Sues TESARO Over License Agreement Breach
2M ago
AnaptysBio announces $100M share repurchase program
PremiumThe FlyAnaptysBio announces $100M share repurchase program
2M ago
GSK subsidiary initiates litigation against AnaptysBio
Premium
The Fly
GSK subsidiary initiates litigation against AnaptysBio
2M ago
AnaptysBio price target lowered to $52 from $59 at H.C. Wainwright
Premium
The Fly
AnaptysBio price target lowered to $52 from $59 at H.C. Wainwright
2M ago
AnaptysBio: Phase 2 rosnilimab trial did not meet primary, secondary endpoints
PremiumThe FlyAnaptysBio: Phase 2 rosnilimab trial did not meet primary, secondary endpoints
2M ago
AnaptysBio trading halted, news pending
Premium
The Fly
AnaptysBio trading halted, news pending
2M ago
AnaptysBio’s Strategic Split and Robust Pipeline Justify Buy Rating
Premium
Ratings
AnaptysBio’s Strategic Split and Robust Pipeline Justify Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100